Treatments for angiosarcoma can be intense, and it is important to monitor how your body responds. Common side effects include: Surgical Recovery: Pain, swelling and a limited range of motion in the ...

As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...

We were downsizing, simplifying, really, and with that came the familiar rhythm of sorting, deciding, letting go. By now, we had done this enough to know the routine: keep what matters, release what ...

Join Dr. Sara Nunnery, Director of Breast Cancer Research at Tennessee Oncology, on the “Breast Cancer Briefing” podcast. This series offers expert analysis of the latest breast cancer clinical trials ...

When your skin senses UV radiation, melanocytes, the cells responsible for pigment, produce melanin as a shield to protect ...

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder ...

A new clinical trial is enrolling up to 60 children and young people with solid tumors across the United States and United ...

Multiple myeloma research led by researchers at the University of Calgary identified how tumor cells adapt after ...

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

Darlifarnib is an investigational next-generation farnesyl transferase inhibitor designed to interfere with cellular pathways ...

Tamera Anderson-Hanna reflects on survivorship, redefining life with family, travel, purpose and giving back while embracing ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...